← Leaderboards
Peter Libby
Brigham And Women'S Hospital
$39,585,619
Attributed
$39,585,619
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$46,504,806 · 18
By mechanism
R01$18,914,175 · 10
T32$17,261,944 · 1
P01$8,572,070 · 4
R37$1,222,655 · 1
P50$513,962 · 1
R13$20,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Guo-Ping Shi$19,551,120
- Glenn T Furuta$8,443,753
- Craig M Lilly$5,555,420
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisInflammationCytokineCardiovascular SystemMacrophageArterial Fatty StreakCellsProteinsGrantEventTrainingLesionSiteIn VivoMolecularHuman TissueAtherogenesisRisk FactorsBlood VesselsLaboratory MouseBloodInflammatoryBone MarrowIn Vitro
Grant awards (88)
Role of CLCA1 as a MIF decoy inhibitor in abdominal aortic aneurysms$714,415
R01 · FY2025 · HL · contact PI
Role of eosinophil cationic proteins in cardiac hypertrophy$713,655
R01 · FY2025 · HL · contact PI
Role of group 2 innate lymphoid cells in myocardial infarction$682,143
R01 · FY2025 · HL · contact PI
Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis$650,445
R01 · FY2025 · HL · contact PI
Training Grant in Cardiovascular Research$806,952
T32 · FY2024 · HL · contact PI
Role of eosinophil cationic proteins in cardiac hypertrophy$699,381
R01 · FY2024 · HL · contact PI
Role of group 2 innate lymphoid cells in myocardial infarction$668,501
R01 · FY2024 · HL · contact PI
Role of ILC2 and eosinophils in abdominal aortic aneurysm$666,455
R01 · FY2024 · HL · contact PI
Role of CLCA1 as a MIF decoy inhibitor in abdominal aortic aneurysms$642,976
R01 · FY2024 · HL · contact PI
Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis$637,436
R01 · FY2024 · HL · contact PI
Role of Mast cells in Alzheimer's Disease$617,880
R01 · FY2024 · AG · contact PI
Training Grant in Cardiovascular Research$961,286
T32 · FY2023 · HL · contact PI
Role of eosinophil cationic proteins in cardiac hypertrophy$713,654
R01 · FY2023 · HL · contact PI
Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis$650,445
R01 · FY2023 · HL · contact PI
Role of Mast cells in Alzheimer's Disease$617,880
R01 · FY2023 · AG · contact PI
Training Grant in Cardiovascular Research$937,798
T32 · FY2022 · HL · contact PI
Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis$646,417
R01 · FY2022 · HL · contact PI
Novel mechanisms of the thrombotic complications of atherosclerosis$420,956
R01 · FY2022 · HL · contact PI
Training Grant in Cardiovascular Research$898,162
T32 · FY2021 · HL · contact PI
Novel mechanisms of the thrombotic complications of atherosclerosis$420,956
R01 · FY2021 · HL · contact PI
Training Grant in Cardiovascular Research$884,826
T32 · FY2020 · HL · contact PI
Novel mechanisms of the thrombotic complications of atherosclerosis$420,956
R01 · FY2020 · HL · contact PI
Training Grant in Cardiovascular Research$730,959
T32 · FY2019 · HL · contact PI
Novel mechanisms of the thrombotic complications of atherosclerosis$420,956
R01 · FY2019 · HL · contact PI
Training Grant in Cardiovascular Research$826,479
T32 · FY2018 · HL · contact PI
Molecular Determinants of Arterial Remodeling in Atherogenesis$425,150
R01 · FY2018 · HL · contact PI
Training Grant in Cardiovascular Research$803,548
T32 · FY2017 · HL · contact PI
Molecular Determinants of Arterial Remodeling in Atherogenesis$425,150
R01 · FY2017 · HL · contact PI
Training Grant in Cardiovascular Research$11,035
T32 · FY2017 · HL · contact PI
Training Grant in Cardiovascular Research$791,845
T32 · FY2016 · HL · contact PI
Molecular Determinants of Arterial Remodeling in Atherogenesis$425,150
R01 · FY2016 · HL · contact PI
Training Grant in Cardiovascular Research$769,394
T32 · FY2015 · HL · contact PI
Molecular Determinants of Arterial Remodeling in Atherogenesis$425,055
R01 · FY2015 · HL · contact PI
Training Grant in Cardiovascular Research$631,819
T32 · FY2014 · HL · contact PI
REDOX BIOMARKERS$104,959
P01 · FY2014 · HL · contact PI
Training Grant in Cardiovascular Research$679,596
T32 · FY2013 · HL · contact PI
Molecular Determinants of Arterial Remodeling in Atherogenesis$403,860
R01 · FY2013 · HL · contact PI
REDOX BIOMARKERS$101,960
P01 · FY2013 · HL · contact PI
Training Grant in Cardiovascular Research$679,596
T32 · FY2012 · HL · contact PI
Molecular Determinants of Arterial Remodeling in Atherogenesis$424,223
R01 · FY2012 · HL · contact PI
REDOX BIOMARKERS$107,102
P01 · FY2012 · HL · contact PI
Training Grant in Cardiovascular Research$670,051
T32 · FY2011 · HL · contact PI
Molecular Determinants of Arterial Remodeling in Atherogenesis$427,565
R01 · FY2011 · HL · contact PI
REDOX BIOMARKERS$107,102
P01 · FY2011 · HL · contact PI
Training Grant in Cardiovascular Research$659,307
T32 · FY2010 · HL · contact PI
Molecular Determinants of Arterial Remodeling in Atherogenesis$425,500
R01 · FY2010 · HL · contact PI
REDOX BIOMARKERS$106,945
P01 · FY2010 · HL · contact PI
Training Grant in Cardiovascular Research$411,330
T32 · FY2009 · HL · contact PI
Tissue Analyses$176,617
P01 · FY2009 · HL · contact PI
Training Grant in Cardiovascular Research$556,571
T32 · FY2008 · HL · contact PI
Determinants of Arterial Remodeling in Atherogenesis$414,829
R01 · FY2008 · HL · contact PI
Tissue Analyses$170,576
P01 · FY2008 · HL · contact PI
Training Grant in Cardiovascular Research$617,193
T32 · FY2007 · HL · contact PI
Determinants of Arterial Remodeling in Atherogenesis$414,829
R01 · FY2007 · HL · contact PI
Tissue Analyses$166,939
P01 · FY2007 · HL · contact PI
Training Grant in Cardiovascular Research$617,193
T32 · FY2006 · HL · contact PI
Inflammatory Mechanisms of Atherosclerosis$479,281
R01 · FY2006 · HL · contact PI
Determinants of Arterial Remodeling in Atherogenesis$427,219
R01 · FY2006 · HL · contact PI
Tissue Analyses$171,078
P01 · FY2006 · HL · contact PI
MOLECULAR DETERMINANTS OF THE STABILITY OF ATHEROMA$48,533
P50 · FY2006 · HL · contact PI
Training Grant in Cardiovascular Research$581,635
T32 · FY2005 · HL
Inflammatory Mechanisms of Atherosclerosis$479,375
R01 · FY2005 · HL
Determinants of Arterial Remodeling in Atherogenesis$406,096
R01 · FY2005 · HL
Tissue Analyses$165,775
P01 · FY2005 · HL
Atherothrombosis$20,000
R13 · FY2005 · HL
Inflammatory Mechanisms of Atherosclerosis$468,155
R01 · FY2004 · HL
Training Program in Cardiovascular Research$454,867
T32 · FY2004 · HL
MOLECULAR DETERMINANTS OF THE STABILITY OF ATHEROMA$48,533
P50 · FY2004 · HL
ARTERIAL DYSFUNCTION--BASIC AND CLINICAL MECHANISMS$1,786,946
P01 · FY2003 · HL
TRAINING PROGRAM IN CARDIOVASCULAR RESEARCH$619,072
T32 · FY2003 · HL
Inflammatory Mechanisms of Atherosclerosis$454,519
R01 · FY2003 · HL
ARTERIAL DYSFUNCTION--BASIC AND CLINICAL MECHANISMS$1,748,273
P01 · FY2002 · HL
TRAINING PROGRAM IN CARDIOVASCULAR RESEARCH$599,010
T32 · FY2002 · HL
CONTROL OF GROWTH OF VASCULAR WALL CELLS$419,657
R37 · FY2002 · HL
PATHOGENESIS OF TRANSPLANT ASSOCIATED ARTERIOSCLEROSIS$333,536
R01 · FY2002 · HL
INFLAMMATORY AND INFECTIOUS MECHANISMS IN ATHEROGENESIS$0
P01 · FY2002 · HL
ARTERIAL DYSFUNCTION--BASIC AND CLINICAL MECHANISMS$1,710,729
P01 · FY2001 · HL
TRAINING PROGRAM IN CARDIOVASCULAR RESEARCH$536,664
T32 · FY2001 · HL
CONTROL OF GROWTH OF VASCULAR WALL CELLS$407,434
R37 · FY2001 · HL
PATHOGENESIS OF TRANSPLANT ASSOCIATED ARTERIOSCLEROSIS$327,513
R01 · FY2001 · HL
MOLECULAR DETERMINANTS OF THE STABILITY OF ATHEROMA$48,533
P50 · FY2001 · HL
INFLAMMATORY AND INFECTIOUS MECHANISMS IN ATHEROGENESIS$0
P01 · FY2001 · HL
ARTERIAL DYSFUNCTION--BASIC AND CLINICAL MECHANISMS$1,673,239
P01 · FY2000 · HL
TRAINING PROGRAM IN CARDIOVASCULAR RESEARCH$525,756
T32 · FY2000 · HL
CONTROL OF GROWTH OF VASCULAR WALL CELLS$395,564
R37 · FY2000 · HL
MOLECULAR DETERMINANTS OF THE STABILITY OF ATHEROMA$368,363
P50 · FY2000 · HL
PATHOGENESIS OF TRANSPLANT ASSOCIATED ARTERIOSCLEROSIS$321,663
R01 · FY2000 · HL
INFLAMMATORY AND INFECTIOUS MECHANISMS IN ATHEROGENESIS$273,830
P01 · FY2000 · HL